WORCESTER, Mass.--(BUSINESS WIRE)--Jan. 4, 2006--Biovest International, Inc. (OTCBB:BVTI), a biopharmaceutical company focused on the development of patient specific immunotherapeutics and automated cell culture instrumentation announced that Donna Jordan has joined the company as Vice President of Quality Control and Quality Assurance. Most recently, Ms. Jordan was Director of Quality Systems at RenaMed Biologics in Lincoln, RI where she was responsible for the Quality Assurance, Quality Control and Validation departments in support of the initiation of in-house manufacturing of a combination product currently in Phase 2 clinical trials. Her previous positions include Director of Quality Assurance at VI Technologies in Watertown, Mass. and Director of Quality Systems at Q-One Biotech in Worcester, Mass. From 1990-2000 Ms Jordan held positions of increasing responsibility at Seragen in Hopkinton, Mass., rising to the position of Manager, Quality Assurance. At Seragen she played a key role in bringing a biologic product (Ontak, for cutaneous T-cell lymphoma) from development through commercialization.